PureHealth Holding, the largest healthcare group in the Middle East, reported strong financial results for the nine months ending September 30, 2025, with revenue reaching AED20.1bn ($5.47bn), a six per cent year-on-year increase.
EBITDA rose 11 per cent to AED3.5bn ($952.8m), while net profit climbed eight per cent to AED1.55bn ($422m).
The company attributed the growth to solid performance across its healthcare (Care) and insurance (Cover) verticals, alongside the completion of its acquisition of Hellenic Healthcare Group (HHG) in the third quarter.
Global expansion drives performance
The acquisition of HHG, valued at €800m(AED3.1bn/$846.6m), marked a major step in PureHealth’s international expansion.
The deal adds 11 hospitals and 23 diagnostic centres in Greece and Cyprus, strengthening the group’s clinical, operational and research capabilities across global markets.
Kamal Al Maazmi, Chairman of PureHealth, said the results reflect the strength of the group’s integrated model and long-term vision, adding that the company’s expansion and continued investment in digital and clinical capabilities position it for sustainable growth.
Group CEO Shaista Asif said the company made strong progress in scaling its network and global reach.
She said: “Growth was driven by solid execution across both Care and Cover segments, with rising patient engagement, higher diagnostic activity, and strong insurance renewals.
“The acquisition of Hellenic Healthcare Group marks a step-change in our global capabilities, while ongoing investment in digital infrastructure enables more efficient, connected and personalised care”.
Care and Cover segments report double-digit gains
Within the Care vertical, revenue rose three per cent to AED14.4bn ($3.92bn), supported by a 12 per cent increase in outpatient volumes and nine per cent growth in inpatient volumes across the UAE and UK networks.
UAE operations saw strong expansion in outpatient capacity, diagnostics and surgical care, while Circle Health in the UK recorded notable growth in orthopaedics, cardiology, oncology and general medicine.
The Cover vertical achieved 13 per cent revenue growth to AED5.7bn ($1.55bn), driven by a seven per cent rise in memberships to 3.3m and a seven per cent increase in gross written premiums to AED5.9bn ($1.6bn).
Technology and AI powering efficiency
PureHealth continued to integrate digital and AI technologies across its operations.
Daman, the group’s health insurance arm, deployed an AI-powered document intelligence platform that processes over 60m documents annually, improving speed and accuracy in claims and customer management.
Meanwhile, Rafed was appointed exclusive distributor for Abu Dhabi’s Unified Procurement Programme and as logistics partner for the regional vaccine distribution hub.
Outlook: expanding footprint and AI capabilities
With 52 per cent of its assets now outside the UAE, PureHealth plans to expand its global footprint further, deepen clinical specialisation, and accelerate AI-driven healthcare solutions.
The group said it remains focused on delivering sustainable growth and long-term value for patients, partners and shareholders.
Follow us on
